IW-9179 + Matching Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Diabetic Gastroparesis
Conditions
Diabetic Gastroparesis
Trial Timeline
Oct 1, 2014 → Dec 1, 2015
NCT ID
NCT02289846About IW-9179 + Matching Placebo
IW-9179 + Matching Placebo is a phase 2 stage product being developed by Ironwood Pharmaceuticals for Diabetic Gastroparesis. The current trial status is completed. This product is registered under clinical trial identifier NCT02289846. Target conditions include Diabetic Gastroparesis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02289846 | Phase 2 | Completed |
Competing Products
20 competing products in Diabetic Gastroparesis